Hasil Pencarian - Carl Walkey

  • Menampilkan 1 - 3 hasil dari 3
Perbaiki Hasil
  1. 1
    898 Intratumoral administration of NL-201, an alpha-independent IL-2/15 receptor agonist, inhibits the growth of both injected and uninjected tumors in preclinical models

    898 Intratumoral administration of NL-201, an alpha-independent IL-2/15 receptor agonist, inhibits the growth of both injected and uninjected tumors in preclinical models oleh Kevin Yu, Ryan Swanson, Carl Walkey, Justin Huard, Laurie Tatalick, Marianne Riley

    Diterbitkan 2021-11-01
    Artikel
    Simpan ke Daftar
    Disimpan di:
  2. 2
    716 NL-201 induces inflammation in a 'cold' tumor microenvironment through upregulation of MHC-I, expansion of the TCR repertoire, and potent antitumor activity when combined with PD-1 inhibition

    716 NL-201 induces inflammation in a 'cold' tumor microenvironment through upregulation of MHC-I, expansion of the TCR repertoire, and potent antitumor activity when combined with... oleh Ryan Swanson, Carl Walkey, Christie Mortales, Benjamin Dutzar, Jerry Chen, Alex Chen, Justin Huard, Luis Blancas-Mejia

    Diterbitkan 2021-11-01
    Artikel
    Simpan ke Daftar
    Disimpan di:
  3. 3
    563 ICT01, an anti-BTN3A mAb, and NL-201, an alpha-independent IL-2/IL-15 agonist, combine to elicit a potent anti-tumor response by synergistically stimulating Vg9Vd2 T cell activation and proliferation

    563 ICT01, an anti-BTN3A mAb, and NL-201, an alpha-independent IL-2/IL-15 agonist, combine to elicit a potent anti-tumor response by synergistically stimulating Vg9Vd2 T cell activ... oleh Ryan Swanson, Aude de Gassart, Patrick Brune, Sophie Agaugué, Paul Frohna, Loui Madakamutil, Maelle Mairesse, Carl Walkey

    Diterbitkan 2021-11-01
    Artikel
    Simpan ke Daftar
    Disimpan di:

Alat Pencarian: